The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 11, 2026 | Choi Jung | Director | Grant(A) | 65K | — | $0 |
| Jun 11, 2026 | Carson William H. | Director | Grant(A) | 65K | — | $0 |
| Jun 11, 2026 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | Option exercise(M) | 31K | $1.85 | $57K |
| Jun 11, 2026 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | Option exercise(M) | 31K | — | $0 |
| Jun 11, 2026 | Waddill William D. | Director | Grant(A) | 65K | — | $0 |
| Jun 11, 2026 | Satter Muneer A | Director | Grant(A) | 65K | — | $0 |
| Jun 11, 2026 | Jones William A JR | Director | Grant(A) | 65K | — | $0 |
| Jun 11, 2026 | Cockroft Bettina M. | Director | Grant(A) | 65K | — | $0 |
| May 28, 2026 | Satter Muneer A | Director | Buy(P) | 613K | $5.41 | $3.3M |
| May 11, 2026 | Carson William H. | Director | Buy(P) | 8K | $5.78 | $46K |
| Apr 10, 2026 | Carson William H. | Director | Buy(P) | 8K | $6.20 | $50K |
| Mar 10, 2026 | Carson William H. | Director | Buy(P) | 8K | $5.67 | $45K |
| Mar 2, 2026 | Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | Sell(S) | 6K | $5.42 | $30K |
| Mar 2, 2026 | Dananberg Jamie | CHIEF MEDICAL OFFICER | Sell(S) | 6K | $5.43 | $32K |
| Mar 2, 2026 | Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | Sell(S) | 4K | $5.42 | $24K |
| Mar 2, 2026 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | Sell(S) | 6K | $5.42 | $30K |
| Mar 2, 2026 | Artis Dean Richard | EVP & CHIEF SCIENTIFIC OFFICER | Sell(S) | 6K | $5.43 | $32K |
| Feb 19, 2026 | Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | Grant(A) | 63K | — | $0 |
| Feb 19, 2026 | Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | Grant(A) | 250K | — | $0 |
| Feb 19, 2026 | Dananberg Jamie | CHIEF MEDICAL OFFICER | Grant(A) | 56K | — | $0 |
| Feb 19, 2026 | Dananberg Jamie | CHIEF MEDICAL OFFICER | Grant(A) | 225K | — | $0 |
| Feb 19, 2026 | Love Douglas | PRESIDENT AND CEO, Director | Grant(A) | 1.3M | — | $0 |
| Feb 19, 2026 | Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | Grant(A) | 63K | — | $0 |
| Feb 19, 2026 | Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | Grant(A) | 250K | — | $0 |
| Feb 19, 2026 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | Grant(A) | 63K | — | $0 |
| Feb 19, 2026 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | Grant(A) | 250K | — | $0 |
| Feb 19, 2026 | Artis Dean Richard | EVP & CHIEF SCIENTIFIC OFFICER | Grant(A) | 63K | — | $0 |
| Feb 19, 2026 | Artis Dean Richard | EVP & CHIEF SCIENTIFIC OFFICER | Grant(A) | 250K | — | $0 |
| Feb 18, 2026 | Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | Sell(S) | 8K | $5.11 | $40K |
| Feb 18, 2026 | Dananberg Jamie | CHIEF MEDICAL OFFICER | Sell(S) | 5K | $5.10 | $27K |
| Feb 18, 2026 | Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | Sell(S) | 6K | $5.10 | $32K |
| Feb 18, 2026 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | Sell(S) | 8K | $5.11 | $40K |
| Feb 18, 2026 | Artis Dean Richard | EVP & CHIEF SCIENTIFIC OFFICER | Sell(S) | 5K | $5.10 | $27K |
| Dec 30, 2025 | Carson William H. | Director | Buy(P) | 4K | $5.02 | $21K |
| Dec 1, 2025 | Choi Jung | Director | Buy(P) | 33K | $4.19 | $138K |
| Dec 1, 2025 | Carson William H. | Director | Buy(P) | 4K | $4.47 | $18K |
| Nov 21, 2025 | Satter Muneer A | Director | Buy(P) | 423K | $4.28 | $1.8M |
| Nov 20, 2025 | Satter Muneer A | Director | Buy(P) | 400K | $4.48 | $1.8M |
| Nov 19, 2025 | Satter Muneer A | Director | Buy(P) | 500K | $3.94 | $2.0M |
| Nov 18, 2025 | Satter Muneer A | Director | Buy(P) | 500K | $3.18 | $1.6M |
| Nov 17, 2025 | Satter Muneer A | Director | Buy(P) | 500K | $2.99 | $1.5M |
| Oct 30, 2025 | Carson William H. | Director | Buy(P) | 4K | $3.17 | $13K |
| Sep 30, 2025 | Carson William H. | Director | Buy(P) | 4K | $3.05 | $13K |
| Sep 2, 2025 | Carson William H. | Director | Buy(P) | 4K | $2.09 | $9K |
| Jul 30, 2025 | Carson William H. | Director | Buy(P) | 4K | $2.43 | $10K |
| Jul 14, 2025 | Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | Sell(S) | 853 | $2.61 | $2K |
| Jul 14, 2025 | Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | Sell(S) | 1K | $2.58 | $3K |
| Jul 14, 2025 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | Sell(S) | 1K | $2.58 | $3K |
| Jun 30, 2025 | Carson William H. | Director | Buy(P) | 4K | $2.46 | $10K |
| Jun 5, 2025 | Cockroft Bettina M. | Director | Grant(A) | 55K | — | $0 |
| Jun 5, 2025 | Jones William A JR | Director | Grant(A) | 55K | — | $0 |
| Jun 5, 2025 | Choi Jung | Director | Grant(A) | 55K | — | $0 |
| Jun 5, 2025 | Carson William H. | Director | Grant(A) | 55K | — | $0 |
| Jun 5, 2025 | Waddill William D. | Director | Grant(A) | 55K | — | $0 |
| Jun 5, 2025 | Satter Muneer A | Director, 10% Owner | Grant(A) | 55K | — | $0 |
| Jun 5, 2025 | Wiggans Thomas G | Director | Grant(A) | 55K | — | $0 |
| Feb 27, 2025 | Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | Grant(A) | 273K | — | $0 |
| Feb 27, 2025 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | Grant(A) | 273K | — | $0 |
| Feb 27, 2025 | Love Douglas | PRESIDENT AND CEO, Director | Grant(A) | 1.3M | — | $0 |
| Feb 27, 2025 | Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | Grant(A) | 273K | — | $0 |
| Feb 27, 2025 | Dananberg Jamie | CHIEF MEDICAL OFFICER | Grant(A) | 228K | — | $0 |
| Feb 27, 2025 | Artis Dean Richard | EVP & CHIEF SCIENTIFIC OFFICER | Grant(A) | 273K | — | $0 |
| Feb 18, 2025 | Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | Sell(S) | 7K | $2.92 | $20K |
| Feb 18, 2025 | Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | Sell(S) | 7K | $2.95 | $20K |
| Feb 18, 2025 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | Sell(S) | 8K | $2.91 | $24K |
| Feb 18, 2025 | Artis Dean Richard | EVP & CHIEF SCIENTIFIC OFFICER | Sell(S) | 6K | $2.97 | $16K |
| Feb 18, 2025 | Dananberg Jamie | CHIEF MEDICAL OFFICER | Sell(S) | 6K | $2.96 | $16K |
| Feb 13, 2025 | Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | Sell(S) | 1K | $2.99 | $4K |
| Feb 13, 2025 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | Sell(S) | 2K | $2.99 | $5K |
| Feb 13, 2025 | Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | Sell(S) | 2K | $2.98 | $5K |
| Feb 13, 2025 | Love Douglas | PRESIDENT AND CEO, Director | Sell(S) | 5K | $2.95 | $15K |
| Jan 9, 2025 | Jones William A JR | Director | Grant(A) | 88K | — | $0 |
| Jan 6, 2025 | Love Douglas | PRESIDENT AND CEO, Director | Option exercise(M) | 38K | $1.41 | $54K |
| Jan 6, 2025 | Love Douglas | PRESIDENT AND CEO, Director | Option exercise(M) | 38K | — | $0 |
| Dec 2, 2024 | Carson William H. | Director | Buy(P) | 3K | $5.33 | $17K |
| Oct 30, 2024 | Love Douglas | PRESIDENT AND CEO, Director | Option exercise(M) | 78K | $1.85 | $145K |
| Oct 30, 2024 | Love Douglas | PRESIDENT AND CEO, Director | Option exercise(M) | 36K | $1.85 | $67K |
| Oct 30, 2024 | Love Douglas | PRESIDENT AND CEO, Director | Option exercise(M) | 36K | — | $0 |
| Oct 30, 2024 | Love Douglas | PRESIDENT AND CEO, Director | Option exercise(M) | 78K | — | $0 |
| Oct 15, 2024 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | Option exercise(M) | 5K | $1.85 | $10K |
| Oct 15, 2024 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | Sell(S) | 5K | $7.41 | $40K |
| Oct 15, 2024 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | Option exercise(M) | 5K | — | $0 |
| Oct 1, 2024 | Carson William H. | Director | Buy(P) | 3K | $5.97 | $19K |
| Sep 19, 2024 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | Sell(S) | 5K | $7.10 | $32K |
| Sep 12, 2024 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | Sell(S) | 6K | $6.16 | $34K |
| Sep 5, 2024 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | Sell(S) | 6K | $5.64 | $31K |
| Sep 3, 2024 | Carson William H. | Director | Buy(P) | 3K | $5.48 | $18K |
| Aug 29, 2024 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | Sell(S) | 6K | $5.95 | $33K |
| Aug 1, 2024 | Carson William H. | Director | Buy(P) | 3K | $6.24 | $20K |
| Jul 15, 2024 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | Sell(S) | 1K | $6.02 | $7K |
| Jul 15, 2024 | Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | Sell(S) | 1K | $6.03 | $7K |
| Jul 15, 2024 | Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | Sell(S) | 784 | $6.02 | $5K |
| Jul 1, 2024 | Carson William H. | Director | Buy(P) | 3K | $5.00 | $16K |
| Jun 5, 2024 | Cockroft Bettina M. | Director | Grant(A) | 44K | — | $0 |
| Jun 5, 2024 | Carson William H. | Director | Grant(A) | 44K | — | $0 |
| Jun 5, 2024 | Waddill William D. | Director | Grant(A) | 44K | — | $0 |
| Jun 5, 2024 | Choi Jung | Director | Grant(A) | 44K | — | $0 |
| Jun 5, 2024 | Satter Muneer A | Director, 10% Owner | Grant(A) | 44K | — | $0 |
| Jun 5, 2024 | Wiggans Thomas G | Director | Grant(A) | 44K | — | $0 |
| Jun 3, 2024 | Carson William H. | Director | Buy(P) | 3K | $4.83 | $15K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).